Lori M. Laffel

Active 1988–2025

200
Papers
32,791
Citations
90
h-index
191
i10-index

Citations

Citations per year for Lori M. Laffel1984: 1 citations1988: 5 citations1989: 4 citations1990: 7 citations1991: 5 citations1992: 9 citations1993: 10 citations1994: 10 citations1995: 9 citations1996: 21 citations1997: 22 citations1998: 23 citations1999: 24 citations2000: 33 citations2001: 56 citations2002: 47 citations2003: 62 citations2004: 57 citations2005: 89 citations2006: 88 citations2007: 105 citations2008: 104 citations2009: 167 citations2010: 137 citations2011: 138 citations2012: 143 citations2013: 162 citations2014: 177 citations2015: 169 citations2016: 151 citations2017: 142 citations2018: 271 citations2019: 894 citations2020: 1,145 citations2021: 1,209 citations2022: 1,164 citations2023: 1,032 citations2024: 1,595 citations2025: 752 citations2026: 47 citations1985–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,985 citing papers, 28.6% of this breakdownUnited Kingdom: 889 citing papers, 8.5% of this breakdownItaly: 517 citing papers, 5% of this breakdownChina: 503 citing papers, 4.8% of this breakdownAustralia: 466 citing papers, 4.5% of this breakdownCanada: 457 citing papers, 4.4% of this breakdownGermany: 428 citing papers, 4.1% of this breakdownDenmark: 282 citing papers, 2.7% of this breakdownNetherlands: 253 citing papers, 2.4% of this breakdownSpain: 241 citing papers, 2.3% of this breakdownSweden: 224 citing papers, 2.2% of this breakdownFrance: 219 citing papers, 2.1% of this breakdown
0%28.6%Other 28.4%

Fields

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Health Professions5%
  • Engineering1.9%
  • Psychology1.5%
  • Immunology and Microbiology1.3%
  • Other3.8%

Topics

  • Diabetes Management and Research20.1%
  • Diabetes and associated disorders9.3%
  • Pancreatic function and diabetes8.3%
  • Diabetes Treatment and Management4.7%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients4.6%
  • Diabetes Management and Education4.3%
  • Other48.7%

Coauthors

All papers

Open in search
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 cited by 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 cited by 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 cited by 2,026

  4. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 965

  5. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 cited by 402

  6. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cari Berget, Susan McCoy, Viral N. Shah, Halis Kaan Aktürk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Pérez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret C. Fisher, Rebecca Ortiz La Banca, Lisa K. Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie Wood, Beth A. Kaminski, Terri Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Johns, Ashwini Gore, L Harvill and 24 more - Diabetes Care 2021 cited by 269

  7. Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

    Authors: , , , , , , , , , , , , , , , , - Analytical Chemistry 2022 cited by 199

  8. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes

    Authors: - Diabetes/Metabolism Research and Reviews 1999 cited by 1,368

  9. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 425

  10. Exercise management in type 1 diabetes: a consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 cited by 890

  11. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 328

  12. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 cited by 237

  13. Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials

    Authors: , , , , , , , , , , - Diabetes Care 2018 cited by 357

  14. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

    Authors: , , , , , , , - Diabetes Care 2018 cited by 510

  15. Advances in technology for management of type 1 diabetes

    Authors: , , , - The Lancet 2019 cited by 238

  16. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minu George, Edgar R. Gonzalez, Michael Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina Huerta‐Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H. Jelley, Ho-Seong Kim, T. A. Kovalenko, Lori M. Laffel, Steven B. Leichter, Raphael Del Roio Liberatore, Jane Lynch, Farid H. Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce Nelson, Luis Alejandro Nevarez Ruiz, Micah L. Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl‐Otfried Schwab, S Shah, Naim Shehadeh, Ashley H. Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, William V. Tamborlane, Eva Tsalikian, Ф. В. Валеева, Carl D Vance, Pedro Velasquez‐Mieyer, R. Ortiz, Olga Votyakova, Haiyan Wei, Ruth S. Weinstock, Mark D. Wheeler, Brandy Wicklow, Steven M. Willi, Kupper A. Wintergerst, Risa M. Wolf, Jamie Wood, Chandan Yaliwal, Hernán Yupanqui Lozno - The Lancet Diabetes & Endocrinology 2023 cited by 103

  17. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

    Authors: , , , , - Diabetes Care 2014 cited by 969

  18. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey

    Authors: , , , , , , , , , , , , , - Diabetes Care 2024 cited by 89

  19. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

    Authors: , , , , , , , - The Lancet Diabetes & Endocrinology 2022 cited by 84

  20. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Turcotte, Lisa K. Volkening, Melissa J. Schoelwer, Sue A. Brown, Katie Krauthause, Emma Emory, Mary Oliveri, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Amy Criego, Betsy L. Schwartz, Laura M. Gandrud, Aimee Grieme, Jamie Hyatt, Daniel J. DeSalvo, Siripoom McKay, Kylie DeLaO, Carolina Villegas, Sarah A. MacLeish, Jamie Wood, Beth A. Kaminski, Terri Casey, Wendy Campbell, Kim Behm, Ramon Adams, David W. Hansen, Sheri Stone, Suzan Bzdick, Jane Bulger, Lynn Agostini, Sarah Doolittle, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin - Diabetes Care 2022 cited by 85

  21. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mei Mei Church, Camille André, Molly Piper, David Lam, Grenye O’Malley, Camilla Levister, Selassie Ogyaadu, Jessica Lovett, Vinaya Simha, Vikash Dadlani, Shelly McCrady-Spitzer, Corey Reid, Kanchan Kumari, Gregory P. Forlenza, G. Todd Alonso, Robert H. Slover, Emily Jost, Laurel H. Messer, Cari Berget, Lindsey Towers, Alex Rossick-Solis, Tali Jacobson, Marissa Town, Ideen Tabatabai, Jordan Keller, Evalina Salas, Francis J. Doyle, Eyal Dassau, Samantha Passman, Tiffany Campos, Carlos Murphy, Nandan Patibandla, Sarah Borgman, Guillermo Arreaza-Rubín, Neal Green, Boris Kovatchev, Sue A. Brown, Stacey Anderson, Marc Breton, Lori Laffel, Jordan Pinsker, Carol J. Levy, R. Paul Wadwa, Bruce A. Buckingham, Francis Doyle, Eric Renard, Claudio Cobelli, Yves Reznik, Guillermo Arreaza-Rubín, John Lum, Roy W. Beck, Robert Janicek, Deanna Gabrielson, Steven H. Belle, Jessica R. Castle, Jennifer Green, Laurent Legault, Steven M. Willi, Carol Wysham, Thomas Eggerman - Diabetes Technology & Therapeutics 2020 cited by 111

  22. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes

    Authors: , , , - Diabetes Technology & Therapeutics 2018 cited by 194

  23. Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents

    Authors: , , , , , , , , , , - JAMA Pediatrics 2018 cited by 186

  24. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

    Authors: , , , , , , , , , , , , - Pediatric Diabetes 2022 cited by 90